http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000513013-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-14 |
| filingDate | 1998-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2000513013-A |
| titleOfInvention | Pyrrolopyrrolones derivatives |
| abstract | (57) Abstract: The present invention relates to a therapeutically effective bicyclic compound, a method for producing the compound, a pharmaceutical composition containing the compound, particularly a viral infection, and more specifically, a virus encoding a serine protease enzyme. In particular the use of this compound in the treatment and prevention of infections caused by viruses of the herpes family. Thus, according to one aspect of the present invention, the present inventors have found that R represents a substituted or unsubstituted C 1-3 alkyl; wherein R 1 is an optionally substituted C 1-3 alkyl. A heteroaryl having 1 to 4 heteroatoms or a fused heteroaryl, R 5 CO, R 5 NHCO, R 5 CS or R 5 NHCS, wherein R 5 is substituted or unsubstituted; H, C 1-6 alkyl, C 1-6 alkenyl, cycloalkyl or fused cycloalkyl, heteroaryl or fused heteroaryl containing 1-4 heteroatoms, aryl or fused aryl, or aryl C 1 -3 alkyl) represents; R 2 is R 6 -X- or R 3 CO (where, R 3 is may not be substituted may be substituted, and, optionally, one or more hetero original May contain a (A), (B), (C), (D), (E), (F), it represents the (G) or an (H)); R 4 is R 6 -X R 6 represents an optionally substituted heterocyclic or fused heterocyclic ring having 1 to 4 heteroatoms, a heteroaryl or fused heteroaryl having 1 to 4 heteroatoms, C 3 -10 cycloalkyl or fused cycloalkyl, aryl, or fused aryl; and, X is C = O, NHC = O, C (= O) C = O, CH = CHCO, CH 2 CO, CH 2 or SO 2 And a salt and a solvate thereof. |
| priorityDate | 1997-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 259.